EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Efecto de la suplementación con vitamina D en pacientes mexicanos con rinitis alérgica

Daniela Rivero-Yeverino, Jonathan Higgins Payan Díaz, Aida Inés López García, José Sergio Papaqui Tapia, Chrystopherson Gengyny Caballero López, Juan Jesús Ríos López, Carlos David López Romero, Johav Yael Sánchez Villalobos, Elisa Ortega-Jorga Rodríguez, Armando Álvarez Rivera, Erika Villada Villada

Revista Alergia México · 2024

DOI: 10.29262/f4jrjv47 ↗
AbstractBibliografische Angaben

Abstract

Objectives: To evaluate the impact of cholecalciferol (D3) supplementation using clinical and paraclinical variables in patients with RA and vitamin D insufficiency and deficiency. Methods: A randomized, double-blind, placebo-controlled study included patients from 5 to 40 years with a diagnosis of RA and vitamin D insufficiency and deficiency. They were supplemented for 8 weeks with 4000 or 5000 IU, depending on age. Total nasal symptoms score (TNSS) was measured monthly and 25(OH)D3 levels at baseline and at the end of the study. Results: A total of 31 patients were included, with a mean age of 18.19 years. In the active group, there was a significant improvement in symptomatology with respect to the TNSS score and an increase in serum vitamin D levels (p < 0.01). There were no adverse reactions with cholecalciferol or placebo. Conclusions: Supplementing patients with vitamin D3, at the evaluated dose, together with conventional treatment for allergic rhinitis results in symptoms and quality of life improvement in patients with this disease. Keywords: Allergic rhinitis, Vitamin D, Placebo, Cholecalciferol, Supplementation.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →